Investigating the anti-cancer activities of the Delta-Tocotrienols and Gamma-Tocopherols on Prostate cancer cells in combination.
The following abstract is taken from a published study and is explained in simple terms to help you understand better. For deeper and technical insights regarding the action of Tocotrienols on human prostate cancer cells, kindly refer to the reference link provided at the bottom of this abstract.



Introduction to Prostate Cancer and TRF
Prostate cancers are caused when the cells of the prostate gland start to multiply uncontrollably. Prostate cancer is the 2nd leading cause of cancer-related deaths in the United States.

In this study, a combination of Delta-Tocotrienols, and Gamma-Tocopherols was investigated for their anticancer properties against prostate cancer cells. Hence, in this study it has been investigated if the combination of both the isomers strengthens the inhibitory effects Delta-Tocotrienols on prostate cancer cell growth.
How does Delta-Tocotrienol fight Prostate Cancer?
In this study, the activities of Annatto Delta-Tocotrienols and Gamma-Tocopherol were investigated against the human androgen-dependent prostate cancer cells (LNCaP). It was observed that the combined treatment of Gamma-Tocopherol and Delta-Tocotrienol resulted in reinforced anti-prostate cancer mechanisms and activities. The combination of both the isomers induced G1 arrest as well as G2/M arrest. The combined treatment also resulted in enhanced induction of apoptosis or programmed cell death in the prostate cancer cells. Hence, it can be concluded from the study that the combination of Gamma-Tocopherol and Delta-Tocotrienol incredibly inhibits the growth of prostate cancer cells due to the simultaneous cell cycle arrest in the G1 as well as the G2/m phase.

To conclude, Tocotrienols have been observed to have high potential in the prevention and treatment of prostate cancer. In vitro studies have shown that Gamma-Tocotrienols promotes apoptosis and autophagy in human prostate cancer cells. Moreover, Tocotrienol rich fraction (TRF) has also displayed chemopreventive and therapeutic activities
Eannatto DeltaGold Tocotrienol contains 90% Delta-Tocotrienol and 10% Gamma-Tocotrienol. One bottle of Eannatto Tocotrienols contains 125g, 60 gels. In studies, 400-900mg of dosage of Tocotrienols, have been suggested by researchers for patients suffering from cancer.
Eannatto Tocotrienol has been derived from the Annatto plant, found in the Amazon which is 100% Tocopherol free. Also, Annatto contains 2x more Tocotrienols than Palm oil and 3x more Tocotrienols than rice bran oil.
Reference for the Study in detail:
5. Agarwal MK, Agarwal ML, Athar M, Gupta S. Tocotrienol-rich fraction of palm oil activates p53, modulates Bax/Bcl2 ratio, and induces apoptosis independent of cell cycle association. Cell Cycle. 2004;3:205–211. [PubMed] [Google Scholar]
6. Ahmad NS, Khalid BA, Luke DA, Ima Nirwana S. Tocotrienol offers better protection than tocopherol from free radical-induced damage of rat bone. Clin Exp Pharmacol Physiol. 2005;32:761–770. [PubMed] [Google Scholar]
7. Ahn KS, Sethi G, Krishnan K, Aggarwal BB. Gamma-tocotrienol inhibits the nuclear factor-kappaB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis. J Biol Chem. 2007;282:809–820. [PubMed] [Google Scholar]
8. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987;47:3239–3245. [PubMed] [Google Scholar]
9. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000;2:76–83. [PubMed] [Google Scholar]
10. Chowdhury S, Burbridge S, Harper PG. Chemotherapy for the treatment of hormone-refractory prostate cancer. Int J Clin Pract. 2007;61:2064–2070. [PubMed] [Google Scholar]
11. Chu Q, Ling MT, Feng H, Cheung HW, Tsao SW, Wang X, Wong YC. A novel anticancer effect of garlic derivatives: inhibition of cancer cell invasion through the restoration of E-cadherin expression. Carcinogenesis. 2006;27:2180–2189. [PubMed] [Google Scholar]
12. Conte C, Floridi A, Aisa C, Piroddi M, Floridi A, Galli F. Gamma-tocotrienol metabolism and antiproliferative effect in prostate cancer cells. Ann NY Acad Sci. 2004;1031:391–394. [PubMed] [Google Scholar]
13. Coppe JP, Itahana Y, Moore DH, Bennington JL, Desprez PY. Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression. Clin Cancer Res. 2004;10:2044–2051. [PubMed] [Google Scholar]
14. Craft N, Chhor C, Tran C, Belldegrun A, DeKernion J, Witte ON, Said J, Reiter RE, Sawyers CL. Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process. Cancer Res. 1999;59:5030–5036. [PubMed] [Google Scholar]
15. Dhanalakshmi S, Singh RP, Agarwal C, Agarwal R. Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis. Oncogene. 2002;21:1759–1767. [PubMed] [Google Scholar]